100 related articles for article (PubMed ID: 15939052)
1. Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice.
Vliegen I; Herngreen SB; Grauls GE; Bruggeman CA; Stassen FR
Atherosclerosis; 2005 Jul; 181(1):39-44. PubMed ID: 15939052
[TBL] [Abstract][Full Text] [Related]
2. Chronic immune reactivity against persisting microbial antigen in the vasculature exacerbates atherosclerotic lesion formation.
Krebs P; Scandella E; Bolinger B; Engeler D; Miller S; Ludewig B
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2206-13. PubMed ID: 17656668
[TBL] [Abstract][Full Text] [Related]
3. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation.
Vliegen I; Duijvestijn A; Grauls G; Herngreen S; Bruggeman C; Stassen F
Microbes Infect; 2004 Jan; 6(1):17-24. PubMed ID: 14738889
[TBL] [Abstract][Full Text] [Related]
5. MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice.
Vliegen I; Stassen F; Grauls G; Blok R; Bruggeman C
J Clin Virol; 2002 Aug; 25 Suppl 2():S159-71. PubMed ID: 12361766
[TBL] [Abstract][Full Text] [Related]
6. Opinion article: cytomegalovirus is a risk factor in atherogenesis.
Reinhardt B; Minisini R; Mertens T
Herpes; 2002 Apr; 9(1):21-3. PubMed ID: 11916496
[TBL] [Abstract][Full Text] [Related]
7. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice.
Berencsi K; Endresz V; Klurfeld D; Kari L; Kritchevsky D; Gönczöl E
Cell Adhes Commun; 1998 Jan; 5(1):39-47. PubMed ID: 9638340
[TBL] [Abstract][Full Text] [Related]
8. Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis.
Vliegen I; Duijvestijn A; Stassen F; Bruggeman C
Microbes Infect; 2004 Oct; 6(12):1056-62. PubMed ID: 15380774
[TBL] [Abstract][Full Text] [Related]
9. Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice.
Rott D; Zhu J; Burnett MS; Zhou YF; Zalles-Ganley A; Ogunmakinwa J; Epstein SE
J Am Coll Cardiol; 2003 May; 41(10):1812-9. PubMed ID: 12767669
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis in apoE knockout mice infected with multiple pathogens.
Burnett MS; Gaydos CA; Madico GE; Glad SM; Paigen B; Quinn TC; Epstein SE
J Infect Dis; 2001 Jan; 183(2):226-231. PubMed ID: 11120928
[TBL] [Abstract][Full Text] [Related]
11. Murine cytomegalovirus infection leads to increased levels of transplant arteriosclerosis in a murine aortic allograft model.
Heim C; Abele-Ohl S; Eckl S; Ramsperger-Gleixner M; Mahmoudian S; Weyand M; Stamminger T; Ensminger SM
Transplantation; 2010 Aug; 90(4):373-9. PubMed ID: 20585280
[TBL] [Abstract][Full Text] [Related]
12. [Fluvastatin's effect on atherogenesis in apolipoprotein-E knockout mice infected by cytomegalovirus].
Yi L; Wang JW; Zhao RG; Tuo HZ; Feng ZJ; Wang DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):433-5. PubMed ID: 21604568
[TBL] [Abstract][Full Text] [Related]
13. Induction of virus specific and H-2 restricted cytotoxic T cells by UV inactivated murine cytomegalovirus.
Sethi KK; Brandis H
Arch Virol; 1979; 60(3-4):227-38. PubMed ID: 228635
[TBL] [Abstract][Full Text] [Related]
14. Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons.
Kosugi I; Kawasaki H; Arai Y; Tsutsui Y
Am J Pathol; 2002 Sep; 161(3):919-28. PubMed ID: 12213720
[TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
Jeitziner SM; Walton SM; Torti N; Oxenius A
Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
Bale JF; O'Neil ME; Lyon B; Perlman S
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
[TBL] [Abstract][Full Text] [Related]
17. Impact of local endothelial challenge with cytomegalovirus or glycoprotein B on vasodilation in intact pressurized arteries from nonpregnant and pregnant mice.
Gombos RB; Teefy J; Lee A; Hemmings DG
Biol Reprod; 2012 Oct; 87(4):83. PubMed ID: 22875909
[TBL] [Abstract][Full Text] [Related]
18. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice.
Yuhasz SA; Dissette VB; Cook ML; Stevens JG
Virology; 1994 Jul; 202(1):272-80. PubMed ID: 8009839
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
Zhou X; Paulsson G; Stemme S; Hansson GK
J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
[TBL] [Abstract][Full Text] [Related]
20. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
Zhang M; Xin H; Duan Y; Atherton SS
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
